Juan José Gorgojo-Martínez

10PUBLICATIONS
25CO-AUTHORS
Solid tumoursNephrology and urologyPharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 13, 2025
Adipocentric Strategy for the Treatment of Type 2 Diabetes Mellitus.

Juan J Gorgojo-Martínez

|Nov 09, 2024
Clinical Recommendations for Managing Genitourinary Adverse Effects in Patients Treated with SGLT-2 Inhibitors: A Multidisciplinary Expert Consensus.

Juan J Gorgojo-Martínez, José L Górriz, Ana Cebrián-Cuenca

|Jul 14, 2023
Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study.

Juan J Gorgojo-Martinez, Pablo José Ferreira-Ocampo, Alba Galdón Sanz-Pastor

|Jun 28, 2023
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes.

Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruiz

|Oct 14, 2022
Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study.

Juan J Gorgojo-Martinez, Miguel Brito-Sanfiel, Teresa Antón-Bravo

|Sep 25, 2020
Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance.

Akshay B Jain, Amar Ali, Juan J Gorgojo Martínez

Pageof 2

Frequent Collaborators

2 joint publications

Jose Luis Gorriz Teruel

2 joint publications

Miguel Brito-Sanfiel

1 joint publications

Akshay B Jain

1 joint publications

Sten Madsbad